Loading clinical trials...
Loading clinical trials...
A Phase I, Double-Blind, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 vs Placebo Administered Intravenously in Healthy Adults
Conditions
Interventions
NTM-1632
Placebo
Locations
1
United States
Duke Human Vaccine Institute - Duke Clinical Vaccine Unit
Durham, North Carolina, United States
Start Date
August 1, 2016
Primary Completion Date
May 31, 2017
Completion Date
May 31, 2017
Last Updated
October 29, 2018
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions